Lupus Clinical Trials

Lupus nephritis is a severe form of systemic lupus erythematosus (SLE) with active disease in the kidneys. SLE is a complex disease in which the body's own immune system attacks some of the body parts: the skin, the joints, the kidneys, the nervous system, the heart, the lungs and the ...

A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE) Patient Inclusion Criteria: Clinical diagnosis of SLE by American College of Rheumatology (ACR) criteria Have positive antinuclear antibodies (ANA) Agree not to become pregnant ...

Local doctors are looking for adults struggling with lupus for clinical research studies of an investigational medication. Doctors are studying this medication to see if it may provide relief with common symptoms associated with lupus.  

The aim of the study is to assess whether an investigational drug is safe and works in people with systemic lupus erthematosus (SLE). The investigational drug will be compared with a placebo. A placebo looks exactly like the investigational drug and is given the same way but contains no active ...

Systemic lupus erythematosus (SLE) is a chronic, often debilitating, multisystem, autoimmune disease that is characterized by the presence of certain cells which directly damage the body’s cells and tissues. SLE can affect multiple organ systems simultaneously or sequentially, and follows a highly variable clinical course where periods of relatively stable ...

Redness, Bumps & Veins caused by Rosacea?  

The total duration of the study is up to 182 weeks, consisting of 3 study periods: a ≤6-week screening period, a 52-week double-blind period, and a 124-week extension period.  

This study is designed to evaluate genetic mechanisms of lung disease by surveying polymorphic genes involved in respiratory function and examining gene expression in the lung cells of individuals with pulmonary disease (e.g., alpha 1-antitrypsin deficiency, asthma, chronic obstructive pulmonary disease, cystic fibrosis, sarcoidosis, history of infection, and genetic mutations ...

Are you hiding because of moderate facial rosacea? A 10 week clinical research study is being conducted to compare two investigational products for the treatment of moderate facial rosacea. Those aged 18 years and up who meet the requirements will have 3 office visits and 1 phone visit. Participants will ...

The study involves one overnight stay at our Raleigh facility and some outpatient visits.